Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients.

ABSTRACT:

Background

Coronavirus disease 2019 (COVID-19) is associated with a hypercoagulable state. Limited data exist informing the relationship between anticoagulation therapy and risk for COVID-19 related hospitalization and mortality.

Methods

We evaluated all patients over the age of 18 diagnosed with COVID-19 in a prospective cohort study from March 4th to August 27th, 2020 among 12 hospitals and 60 clinics of M Health Fairview system (USA). We investigated the relationship between (1) 90-day anticoagulation therapy among outpatients before COVID-19 diagnosis and the risk for hospitalization and mortality and (2) Inpatient anticoagulation therapy and mortality risk.

Findings

Of 6195 patients, 598 were immediately hospitalized and 5597 were treated as outpatients. The over

SUBMITTER: Hozayen SM 

PROVIDER: S-EPMC8461367 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature